La Trobe
1199147_Lopci,E_2022.pdf (1.23 MB)

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0

Download (1.23 MB)
journal contribution
posted on 2022-06-15, 06:32 authored by E Lopci, RJ Hicks, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, RD Seban, C Sachpekidis, O Humbert, O Gheysens, AWJM Glaudemans, W Weber, RL Wahl, Andrew ScottAndrew Scott, N Pandit-Taskar, N Aide

Purpose: The goal of this guideline/procedure standard is to assist nuclear medicine physicians, other nuclear medicine professionals, oncologists or other medical specialists for recommended use of [18F]FDG PET/CT in oncological patients undergoing immunotherapy, with special focus on response assessment in solid tumors. Methods: In a cooperative effort between the EANM, the SNMMI and the ANZSNM, clinical indications, recommended imaging procedures and reporting standards have been agreed upon and summarized in this joint guideline/procedure standard. Conclusions: The field of immuno-oncology is rapidly evolving, and this guideline/procedure standard should not be seen as definitive, but rather as a guidance document standardizing the use and interpretation of [18F]FDG PET/CT during immunotherapy. Local variations to this guideline should be taken into consideration. 

Funding

The support for the open-access publication of the current manuscript was provided by the IRCCS -Humanitas Research Hospital, Rozzano (MI), Italy.

History

Publication Date

2022-06-01

Journal

European Journal of Nuclear Medicine and Molecular Imaging

Volume

49

Issue

7

Pagination

(p. 2323-2341)

Publisher

Springer Nature

ISSN

0340-6997

Rights Statement

© The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Usage metrics

    Journal Articles

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC